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Abstract
Introduction: Mycobacterium abscessus is a rapidly growing mycobacterium usually causing skin
and soft tissue infections in immunocompetent patients following contaminated traumatic or
surgical wounds or contaminated injected medications. Disseminated infections and pulmonary
infections are usually reported in immunocompromised hosts.
Case presentation: We describe a 54-year-old Caucasian woman with mastitis due to M.
abscessus. A few days after clinical evidence of mastitis, the patient was started on broad-spectrum
antibiotics. Subsequently, due to persistence of symptoms, a percutaneous breast biopsy was
performed followed by surgical drainage. Initial cultures failed to grow micro-organisms and tissue
histology showed chronic inflammatory reaction with giant cells. Several days after surgery, her
symptoms recurred. Finally, M. abscessus breast infection was diagnosed and the patient was
treated successfully.
Conclusion: Rapidly growing mycobacteria need to be included in the differential diagnosis of
patients with chronic mastitis having pus discharge and who do not respond to broad-spectrum
antibiotics.
Introduction
Mycobacterium abscessus is a rapidly growing mycobacte-
rium [1,2] most commonly causing skin and soft tissue
infections in immunocompetent patients following pene-
trating traumatic injuries and concomitant inoculation of
M. abscessus into the host tissue [1,3]. Other settings of M.
abscessus infections include post-surgical wound infection
[3], eye surgery [4] and post-injection abscess [5]. Podiat-
ric care [6] and body piercing [7] have also been associ-
ated with such infections. Clustered outbreaks or pseudo-
outbreaks have resulted from contaminated ice, water,
injected medications [8] or intra-mammary silicone. Dis-
seminated infections and pulmonary infections are
reported more often in immunocompromised patients
and patients with cystic fibrosis [1,3,9].
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We report the case of a patient with mastitis due to M.
abscessus  who had not undergone surgery nor suffered
local trauma.
Case presentation
A 54-year-old Italian, Caucasian woman with a history of
autoimmune thyroiditis was seen at the surgical unit for
pain, redness and swelling of the left breast which had
developed over the preceding 72 hours. The patient had
been on 10 mg prednisone for 1 month secondary to
autoimmune hemolytic anemia. On physical examina-
tion, she was afebrile. Erythema and edema of both areo-
lar and peri-areolar areas of the left breast were present
with dimensions of about 9 ×6 cm and with homolateral
tender lymph node enlargement. Acute bacterial mastitis
was the initial diagnosis and cefotaxime 2 g/day was pre-
scribed for the first 2 weeks. At this point, due to persist-
ence of symptoms, breast ultrasound, mammography,
fine needle aspiration, and tru-cut needle biopsies were
performed. Histopathology results were consistent with a
chronic inflammatory reaction. Subsequently, a draining
sinus developed and a pus sample was sterile.
One week later, another swab grew both Pseudomonas lute-
ola and Staphylococcus epidermidis prompting us to perform
a second needle aspirate. Cefotaxime 1 g TID and oral cip-
rofloxacin 500 mg BID were prescribed for a total of 3
weeks. During this period, mild improvement was seen
but as the fistula closed her symptoms relapsed so it was
decided to perform surgical excision of the abscess. At sur-
gery, galactophora ducts were found to be filled with
purulent material. Also a mass of 9.5 × 7 × 5 cm, with cav-
itation and purulent material, was excised. Once again,
histopathology reports showed a chronic inflammatory
reaction with giant cells. About 1 week after surgery, the
inflammation reappeared and a third needle aspirate was
performed. This time, M. abscessus was identified and con-
firmed in two subsequent cultures [1,2]. Acid-fast bacilli
(AFB) were also seen in the pus after Zhiel-Neelsen stain-
ing (Figure 1A). At this point, the patient was transferred
to the infectious diseases service.
On admission, the patient had an area of inflammation of
about 6 × 7 × 4 cm in the external quadrants of her left
breast. A few days later, a fistula formed and microbiologi-
cal tests confirmed the presence of M. abscessus.
The isolated strains were identified by the reverse hybrid-
ization method (INNO-LiPA, Belgium) and confirmed by
genetic sequencing [1,2]. Antimycobacterial susceptibility
tests were performed in microdilution broth (MHB,
BioMérieux, France) [10]. M. abscessus results were as fol-
lows: susceptible: clarithromycin (MIC 0.125 mg/L) and
amikacin (MIC 2 mg/L); intermediate susceptible: cefoxi-
tin (MIC 16 mg/L) and imipenem (MIC 8 mg/L); resist-
ant: ciprofloxacin (MIC 8 mg/L), doxycycline (MIC 8 mg/
L), co-trimoxazole (MIC >64 mg/L) and linezolid (MIC
32 mg/L). Abnormal laboratory test results are listed in
Table 1. HIV serology was negative, CD4+ lymphocytes
were normal and blood cultures were negative for AFB.
Therapy consisting of clarithromycin 500 mg BID, imi-
penem 1 g BID and amikacin 1 g/day was started. The lat-
ter was discontinued after 2 weeks due to possible
vestibular side effects. Prednisone was also discontinued
without recurrence of hemolysis. A chest CT scan con-
firmed left breast soft tissue and glandular involvement
(Figure 1B). Thirty-two days after admission, the inflam-
mation was considerably reduced and the patient was dis-
charged on clarithromycin 500 mg twice a day. Only 1
week later, the patient had to be readmitted because of
(A) Acid fast bacilli in pus (arrow) on Zhiel-Neelsen staining;  (B) Chest CT scan showing a soft tissue abscess 4.5 × 3 cm  (arrow) with a cutaneous fistula Figure 1
(A) Acid fast bacilli in pus (arrow) on Zhiel-Neelsen 
staining; (B) Chest CT scan showing a soft tissue 
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recurrence. An ultrasound scan showed a hyperechogenic
area with hypoechogenicity and aspiration was per-
formed. This time, AFBs were not identified in the pus and
the cultures were negative. Imipenem was restarted with
clarithromycin for a further 3 weeks. Thereafter, clarithro-
mycin alone was prescribed for another 10 weeks. Eight-
een months after treatment discontinuation, the patient
remains disease-free.
Discussion
Most  M. abscessus infections in immunocompetent
patients are caused by either post-traumatic or post-surgi-
cal skin and soft tissue inoculation of bacteria [1,3] and
some have nosocomial origins [3]. Our patient had no
soil or gardening exposure, and did not report any other
exposures predisposing to M. abscessus infection. Moreo-
ver, it is most likely that the infection was community-
acquired and its source cannot be established. The low
dose of steroids administered one month before M. absces-
sus  mastitis may have produced some negative immu-
nomodulatory effects predisposing her to infection.
Etiological diagnosis did not occur immediately. Routine
bacterial cultures would not be expected to grow myco-
bacterium, even rapidly growing species.
M. abscessus is resistant to several antibiotics [3,10]. Also,
this isolate was only susceptible to clarithromycin and
amikacin, while cefoxitin and imipenem had intermedi-
ate activity. Our patient received cefotaxime, which had
not been tested in vitro, and ciprofloxacin which was
resistant. In the end, only the combination of clarithro-
mycin, imipenem and amikacin was truly effective. Side
effects included vestibular toxicity and were very likely
due to amikacin. This antimicrobial was, therefore, dis-
continued after 2 weeks and vestibular symptoms
regressed. Imipenem and clarithromycin were continued
for a total of 4 and a half months [3]. Stains and cultures
were negative after the tenth week of treatment.
Conclusion
M. abscessus is a rare cause of skin and soft tissue infection
and should be considered in the differential diagnosis of
patients who do not respond to standard antibacterial
therapy.
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